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ABSTRACT
KLF4 is a transcription factor that is highly
expressed in the gastrointestinal tract. Previously
we have demonstrated that KLF4 represses HDC
promoter activity in a gastric cell line through both
an upstream Sp1 binding GC box and downstream
gastrin responsive elements. However, the mecha-
nism by which KLF4 inhibits HDC promoter is not
well defined. In the current study, by using yeast
two-hybrid screening, Tip60 was identified as
a KLF4 interacting protein. Further coimmunopreci-
pitation and functional reporter assays support the
interaction between these two proteins. In addition,
Tip60 and HDAC7, previously shown to interact with
each other and repress transcription, inhibited HDC
promoter activity in a dose-dependent fashion.
Consistently, knock down of Tip60 or HDAC7 gene
expression by specific shRNA increased endoge-
nous HDC mRNA level. Co-immunoprecipitation
assays showed that HDAC7 was pulled down by
KLF4 and Tip60, suggesting that these three pro-
teins form a repressive complex. Further chromatin
immuno-precipitation indicated that all three pro-
teins associated with HDC promoter. Two-hour
gastrin treatment, known to activate HDC gene
expression, significantly decreased the association
of KLF4, Tip60 and HDAC7 with HDC promoter,
suggesting that gastrin activates HDC gene expres-
sion at least partly by decreasing the formation
of KLF4/Tip60/HDAC7 repressive complexes at the
HDC promoter.
INTRODUCTION
Kruppel-like factor 4 (KLF4), previously known as gut-
enriched Kruppel-like factor, is a transcriptional factor
cloned both in mice (1,2) and in humans (3) that binds
GC-rich DNA sequences having a consensus core DNA
binding sequence of CACCC (1). It is a member of the
Kruppel-like factor (KLF) family, which is highly
expressed in the gastrointestinal tract and other epithelial
tissues (4). KLF4 both activates and represses transcrip-
tion (5–9). Under most conditions, it inhibits cell
proliferation by triggering cell cycle arrest (5,10). Its role
as a cell cycle regulator suggests that it may be a tumor
suppressor, a role supported by the recent data showing
that speciﬁc ablation of KLF4 in the gastric epithelium
of mice results in premalignant changes (11). However,
elevated KLF4 levels have also been linked to cancer.
KLF4 mRNA and protein are overexpressed in most
squamous–cell carcinomas of the oropharynx (12) and
in up to 70% of mammary carcinomas (13). A role for
KLF4 as an oncogene has been further supported by
the induction of squamous epithelial dysplasia by ectopic
KLF4 expression in mice. This paradox was partially
resolved by a recent study showing that p21
Cip1 status may
be a switch that determines the tumor suppressor or
oncoprotein function of KLF4 (14). Animal studies
have indicated that KLF4 is required for terminal
diﬀerentiation of goblet cells in colon (11) and that loss
of KLF4 in mice causes altered proliferation and
diﬀerentiation and precancerous changes in adult stomach
(11). Given the importance of KLF4 in regulating cell
proliferation and diﬀerentiation, it is important to
delineate how KLF4 regulates gene expression at the
molecular level.
Tip60 (Tat-interactive protein, 60kDa) was originally
identiﬁed by yeast two-hybrid screening as a protein that
interacts with the activation domain of the HIV-1
transactivator protein Tat (15). A speciﬁc physical
interaction was further demonstrated by the binding of
expressed Tip60 to puriﬁed Tat in vitro (16). Tip60 belongs
to the HAT family, MYST, which includes MOZ, Ybf2/
Sas3, Sas2 and Tip60 because of their close sequence
similarities (17). Both in vitro and in vivo HAT activities
of Tip60 have been demonstrated, as has the role of Tip60
in DNA repair and apoptosis (18). While Tip60 activates
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acts as a corepressor for STAT3 by the recruitment of
HDAC7 (19). In addition, Tip60 has been implicated
in transcriptional repression through interactions with
CREB or the transcriptional repressor ZEB (Zinc Finger
E Box-binding protein) (16,20). Currently it remains
uncertain how Tip60 functions both as an activator and
a repressor of transcription.
Histidine decarboxylase (HDC) is the only known
enzyme that converts histidine to histamine (21), a
bioamine that plays important roles in many physiological
processes, including allergy, inﬂammation, neurotransmis-
sion and gastric acid secretion (22–24). In the adult
mammal, HDC is highly expressed in enterochromaﬃn-
like (ECL) cells of the stomach, where the HDC activity
is tightly regulated by a gut peptide hormone, gastrin (25).
HDC promoter activity is upregulated by a variety of
stimuli, including gastrin (1), phorbol 12-myristate
13-acetate (PMA) (1,25–27), oxidative stress (28), throm-
bopointin (29), Helicobacter pylori infection (30,31) and
pituitary adenylate cyclase-activating polypeptide
(PACAP) (32). Recently, Ying Yang 1 (YY1), a pleio-
tropic transcription factor which can both upregulate and
downregulate gene expression depending on promoter
context and cellular environment (33,34), was found to
repress the HDC promoter activity through an upstream
GC box (35). In addition, KLF4 has been shown to inhibit
the HDC promoter activity through three elements: the
same upstream GC box and two downstream gastrin
responsive elements (36). These studies have conﬁrmed
that the Sp1 binding GC box plays an important role in
both basal and stimulated HDC gene expression.
However, the precise mechanism of how KLF4 represses
HDC gene expression remains unclear.
MATERIALS AND METHODS
Yeasttwo-hybrid screening
Yeast two-hybrid screening was performed according to
the manufacturer’s instruction (MATCHMAKER Two-
Hybrid System; Clontech). Brieﬂy, DNA sequence of
KLF4 mRNA (AF022184) that encodes amino acid
residues from 170 to 288 aa with EcoRI and BamHI
sites added at the 50 and 30 ends were cloned in-frame into
a yeast two-hybrid system vector pGBKT7 (Clontech, Cat
# K1612-1) digested with EcoRI and BamHI. The reporter
plasmid was then transformed into yeast strain AH109 to
generate the reporter strain with the TRP-selection
medium. Background growth of this reporter strain was
ablated by titrating with 30mM 3-aminotrizole (3-AT)
(Sigma). Screening was carried out by transforming human
lung cDNA library from Clontech (Catalog number
HL4044AH) into the reporter strain. Plasmids were
retrieved from the yeast colonies growing in SD/-Ade/-
His/-Leu/-Trp/X-a-Gal agar plates with 30mM 3-AT.
Plasmids from these clones were then transformed into
DH5a bacterial competent cells (Gibco). The cDNA
inserts were sequenced and then blasted with GenBank
database.
Construction of plasmids
pHA-KLF4 was cloned by PCR with HindIII site at
50 primer and BamHI site at 30 primer to amplify KLF4
sequence from KLF4/HisB (36) and by insertion into
pEP7/HA/FL vector (a kind gift of Dr John Flemming)
predigested with HindIII and BamHI enzymes. Fragments
of diﬀerent KLF4N-terminal truncation mutants,
KLF4AC/HisB (117–471 aa), KLF4BC/HisB (145–471
aa) and KLF4CC/HisB (170–471 aa), were ampliﬁed by
PCR using KLF4/HisB as the template and cloned
in-frame into pcDNA3.1/HisB (named as HisB) using
HindIII and EcoRI sites. All PCR-based constructs were
conﬁrmed by DNA sequencing. pFLAG-Tip60 and
pCMV2-HDAC7 constructs were provided by Dr He-Jin
Lee at Parkinson Institute. GAL4BD-Tip60 constructs
(pM vector, pM-Tip60 and pM-Tip60M with defective
histone acetyltransferase activity) were kindly provided
by Dr Thomas C. Sudhof at University of Texas
Southwestern Medical Center. pCMX constructs
(pCMX vector, pCMX-HDAC1 and pCMX-HDAC7)
were kindly provided by Dr Ronald M Evans at Salk
Institute for Biological Studies. Diﬀerent pM/KLF4
constructs were cloned by PCR. The cloning sites in the
pM vector are EcoRI and HindIII. All the constructs have
been conﬁrmed by DNA sequencing. pCS2+ and GAL4-
VP16/pCS2+ were kindly provided by Dr Scott Frazer at
California Institute of technology.
Cell cultureand transient transfections
AGS and AGS-E cells that stably express CCKB receptor
(36) were grown in complete medium (DMEM containing
10% FCS and 100IU/ml penicillin and 100 mg/ml
streptomycin) in a humidiﬁed atmosphere (5% CO2).
Transient transfections were performed using Superfect
(Qiagen) according to the manufacturer’s protocol. Cells
were seeded to  60% conﬂuence in 12-well plates. Each
well was transfected with 0.005mg of TK renilla luciferase
expression plasmid as an internal control, 0.5mgo f
diﬀerent HDC reporter constructs and 0.5mg of either
the diﬀerent expression plasmids or the empty vector.
Three hours after transfection, media was replaced with
complete medium. For gastrin treatment, cells were
cultured with serum-free medium overnight, and then
stimulated the following day with gastrin (10
 8M) for
indicated time period. If gastrin treatment was not
needed, the cells were cultured in regular medium after
transfection.
Generation ofshRNA expressing cell lines
DNA oligos encoding a shRNA targeting the Tip60
and the HDAC7 genes were designed using the online
software from Invitrogen. The oligonucleotide sequences
are: HDAC7 (AF239243) top strand: 50 CACCGCTG
AAGACCTGGAGACAGATCGAAATCTGTCTCCA
GGTCTTCAGC 30, bottom strand: 50 AAAAGCTGAA
GACCTGGAGACAGATTTCGATCTGTCTCCAGGT
CTTCAGC 30; Tip60 (NM_006388) top strand: 50 CACC
GGATGAATGGGTGACGCATGACGAATCATGCG
TCACCCATTCATCC 30, bottom strand: 50 AAAAGG
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CCCATTCATCC 30. Top strand oligonucleotide and
bottom strand oligonucleotide were annealed and
cloned into Block-iT
TM U6 RNAi Entry vector using
the manufacturer’s manual (Invitrogen 25-0663). DNA
sequences that encode shRNA targeting the Tip60 and the
HDAC7 genes were then moved to a vector pLenti6/
Block-iTTM-DEST by recombination using the manufac-
turer’s manual (Invitrogen 25-0677). The oligonucleotide
sequences in the ﬁnal constructs were conﬁrmed by DNA
sequencing. The ﬁnal Tip60 and HDAC7 shRNA encod-
ing plasmids were transfected into AGSE cells, and stable
clones that were blasticidin (40mg/ml) resistant were
propagated. Expression levels of RNA were then tested
by real-time PCR. A plasmid that contained DNA
sequence encoding shRNA targeting the LacZ gene was
used to generate a control stable cell line.
Total RNA fromAGS-E cells and quantitative RT-PCR
Cells were grown to 70% conﬂuence in 6-well plates.
Forty-eight hours later, RNA was isolated using Trizol
Reagent (Invitrogen) in accordance with the manufac-
turer’s protocol. After extraction, 5mg of total RNA was
then used as a template to synthesize the complimentary
cDNA using First Strand Synthesis Kit (Invitrogen). The
cDNA from this synthesis was then used in regular reverse
transcript PCR (RT-PCR) and quantitative real-time
PCR (quantitative RT-PCR) analysis using the following
primer pairs of human origin: KLF4-5RT (50 CAAGTC
CCGCCGCTCCATTACCAA 30) and KLF4-3RT (50 CC
ACAGCCGTCCCAGTCACAGTGG 30) for KLF4 gene,
HDC5 (50-AAGATCATCAAGCCGCCTCAGC-30) and
HDC3 (50-AGCGCACCGTCTTCTTCTTAGT-30) for
the HDC gene, Tip60-RT5 (50 TCTCAGACCTTGGCC
TCCTATCCT 30) and Tip60-RT3 (50 CTTCCCCCTCT
TGCTCCAGTCC 30) for Tip60 gene, HDAC7-RT5
(50 CCATGACGACGGCAACTTCTT 30) and HDAC7-
RT3 (50 TGCTGCGTCATGTATCCAAAAC 30) for
HDAC7 gene, and GAPDH-5RT (50 GACATCAA
GAAGGTGGTGAAGC 30) and GAPDH-3RT (50 GTC
CACCACCCTGTTGCTGTAG 30) for GAPDH gene.
Luciferase assays of HDCreporter constructs
After incubation with or without gastrin, cells were
washed with PBS and then incubated with 250mlo f1X
Passive Lysis Buﬀer (Promega) for 20min with constant
shaking. Ten microliters of cell lysate was then assayed
in a Monolight
TM3010 luminometer (Pharmingen). Light
units of each reporter were divided by those of the internal
control, Renilla luciferase, to represent the relative
promoter activity.
Coimmunoprecipitation and western blotting analysis
Combination of diﬀerent constructs including pHA-
KLF4, pFLAG-Tip60, pCMV2-HDAC7 and the vector
controls were cotransfected into AGS cells as described
above. Forty-eight hours after transfection, cells were
harvested and lysed with buﬀer containing 10mM Tris/
HCl (pH 8.0), 300mM NaCl, 1% Triton X-100, plus
proteinase cocktail (Roche, Cat. # 10130500). Cells were
sonicated brieﬂy, and the supernatant was collected by
centrifugation. Five micrograms of rabbit polyclonal
antibodies [anti-KLF4 antibody from Dr Chi-Chuan
Tseng at Boston University, anti-Flag antibody from
Sigma (F3165)] was used to perform immunoprecipita-
tion. Extensively washed immunoprecipitates were
then separated by SDS-PAGE and analyzed by western
blotting with rat monoclonal anti-HA antibody (1:1000,
Roche, Cat # 1867423) to detect KLF4 and with
Polyclonal anti-Flag antibody (1:1000, F3165 from
Sigma) to detect Tip60 and HDAC7. To detect protein
expression after transfection of series of KLF4 truncation
mutant plasmids (pcDNA3.1/His-Myc backbone),
 100mg of total protein was separated on 4–20%
SDS-PAGE, and the proteins were transferred to PVDF
membrane. Western blotting analysis was then performed
using anti-myc-HRP antibody (1:5000, Invitrogen, Cat.
#46-0709) and anti-a-tubulin antibody (1:1000,
Oncogene, Cat. #CP06-100UG) followed by enhanced
chemiluminiscence (ECL) detection procedure.
CHIPs
AGSE cells in 10cm dishes with and without 10
 8M
gastrin treatment were ﬁxed with 1% formaldehyde at
378C for 10min and then harvested and lysed with 500ml
of lysis buﬀer [1%SDS, 5mM EDTA, 50mM Tris/HCl
(pH 8.0), plus protease inhibitor]. After brief sonication
(3 times at 10s each), extracts were precleared by 2mgo f
sheared salmon sperm DNA, 20ml of control IgG and
protein A-Sepharose for 2h at 48C. Twenty microliter
of cleared chromatin extract was used as input control.
Five microgram of antibodies (anti-KLF4 antibody from
Chi-Chuan Tseng at Boston University, anti-Tip60 anti-
body from Upstate, Cat # 07-038, anti-HDAC7 antibody
from Dr Hung-Ying Kao at Case Western University and
anti-acetyl histone 4 antibody from Upstate, Cat # 06-866)
were added to the precleared chromatin preparation and
incubation was carried out overnight at 48C, followed by
addition of 45ml protein A-Sepharose, 2mg of salmon
sperm DNA and incubated for another 1h at 48C.
Sepharose beads were extensively washed sequentially
for 10min in 1ml each TSE I (0.1% SDS, 1% Triton
X-100, 2mM EDTA, 20mM Tris/HCl, pH 8.1, 150mM
NaCl), TSE II (0.1% SDS, 1% Triton X-100, 2mM
EDTA, 20mM Tris/HCl, pH 8.1, 500mM NaCl), buﬀer
III (0.25M LiCl, 1% NP40, 1% deoxycholate, 1mM
EDTA, 10mM Tris/HCl, pH 8.1) and TE buﬀer. DNA
were eluted with 100ml elution buﬀer (1%SDS, 0.1M
NaHCO3) at RT for 10min and elutes were heated at 658C
overnight to reverse the formaldehyde crosslink. DNA
samples were then extracted using the Qiagen PCR
puriﬁcation kit followed by PCR using a pair of primers
to amplify a fragment of human HDC promoter (Top
strand: 50 GAACTGAGGGCTCTTTTACG 30, Bottom
strand: 50 CAGTGTGGGCCCTTTATTTA 30), intron 1
(Top strand: 50 TCTCCCAGGTTCAAGCGATTCT 30,
BottomStrand:50 GACTGGGCCTGACCGATTTGT30),
intron 2 (Top strand: 50 CCTGGGCAACAAGAGCGA
AACT 30, Bottom strand: 50 GCTTAGGCCTCTCATCC
Nucleic Acids Research, 2007, Vol. 35, No. 18 6139CAACACT 30). PCR products were analyzed on 2.0%
agarose gels containing ethidium bromide (0.25mg/l).
RESULTS
Yeasttwo-hybrid screening toidentify KLF4 interacting
proteins
To further understand how KLF4 functions at the
molecular level in diﬀerent physiological events such as
G1/S cell cycle arrest upon DNA damage and oxidative
stress, we identiﬁed proteins interacting with KLF4. Yeast
two-hybrid screening was utilized with two diﬀer-
ent regions of full-length KLF4 protein as baits: the
N-terminal domain containing the activation domain
(aa 1–170) and the middle region containing the repression
domain (aa 170–388). A human lung pACT2 cDNA
library (from Clontech) was used for screening since
KLF4 is expressed in the lung. Because transcriptional
factors have intrinsic transcriptional activities, 40mM
3-AT (3-aminotrizole, a competitive inhibitor of the yeast
HIS3 protein used to suppress background growth on
medium lacking histidine) was added to minimize back-
ground growth during initial screening and the subsequent
conﬁrmation step. Among the positive clones obtained
from this strategy (Table 1), three were found to contain
the in-frame sequence of the Tip60 gene when the middle
region of KLF4 was used as the bait. The high frequency
of Tip60 from this yeast two-hybrid screening strongly
suggests that KLF4 interacts with Tip60.
KLF4interacts withTip60 by coimmunoprecipitation assay
To conﬁrm the interaction between KLF4 and Tip60
coimmunoprecipitation assays were performed. Total
proteins from AGS cells, where both KLF4 and Tip60
were expressed, were immunoprecipitated with anti-KLF4
and anti-Tip60 antibodies followed by western blotting
analysis using anti-Tip60 and anti-KLF4 antibodies,
respectively. As shown in Figure 1A, Tip60 were pulled
down by anti-KLF4 antibody (lane 3), and KLF4 was
pulled down by anti-Tip60 antibody (lane 6) (a very weak
band where KLF4 migrates in lane 5 was observed, but
the signal of the band is several magnitudes weaker than
that of the band in lane 6). In addition, pHA-KLF4 and
pFLAG-Tip60 plasmids were cotransfected into AGS
cells. Forty-eight hours after transfection, cells were
harvested and the total proteins were extracted. Anti-
FLAG and anti-HA antibodies were used to pull down
Tip60 and KLF4, respectively. The immunoprecipitates
were separated by SDS-PAGE gel followed by western
blotting analysis using anti-HA antibody and anti-FLAG
antibody. As shown in Figure 1B (ﬁrst panel), KLF4
successfully pulled down Tip60. Consistently, Tip60 also
pulled down KLF4 (Figure 1B, second panel). These
coimmunoprecipitation data support the physical interac-
tion between KLF4 and Tip60 from the yeast two-hybrid
screening results. To further study the interaction between
KLF4 and Tip60, their subcellular localizations were
examined by immunostaining, using transient transfection
assays in AGS cells. When overexpressed, both KLF4
and Tip60 were predominantly colocalized in the nucleus
(Supplementary Figure 1), which is consistent with the
co-immunoprecipitation data and raises the possibility
that these proteins interact to regulate gene expression.
Functional interactions between KLF4 andTip60
If, as our earlier studies indicated, KLF4 and Tip60
interact, it is possible that KLF4 inﬂuences Tip60-
mediated transcriptional regulation. To test this hypoth-
esis, an in vitro artiﬁcial reporter system was used, in
which Tip60 was recruited to the proximal promoter
region by the GAL4 DNA binding domain in the
construct (Figure 2A). The hypothesis is that because
Tip60 has intrinsic transcriptional activity, its recruitment
to the proximal promoter should result in the transcrip-
tional regulation. As shown in Figure 2B, Tip60 activated
the artiﬁcial reporter activity because of its intrinsic
histone acetyltransferase (HAT) activity (about 3-fold
increase). In the presence of KLF4, Tip60-mediated
transcriptional activation was completely abrogated.
A mutant Tip60, that does not have the HAT activity,
did not activate the transcription in the same assay, and
KLF4, as expected, did not have any eﬀect on this mutant.
Expression of KLF4 had no eﬀect on Tip60 stability at the
protein level (bottom panel of Figure 2B). As a negative
control, overexpression of KLF4 did not inﬂuence the
activation activity of VP16 (Figure 2C) using the same
reporter system. These data suggest that KLF4 speciﬁcally
disrupted Tip60-mediated transcriptional activation.
Furthermore, while full-length KLF4 disrupted Tip60-
mediated transactivation, KLF4 N-terminal truncation
constructs with amino acids 117–470, 145–470 and amino
acids 170–470 (Figure 2D–F) did not show signiﬁcant
disruption in the same assay. This suggests that the
functional domain in KLF4 that mediated this disruption
is located between amino acids 1–117. In a parallel
experiment using a similar reporter system where KLF4
was recruited to the proximal promoter (Figure 3A),
Table 1. Positive clones from yeast two-hybrid screening using two
fragments of KLF4 as the baits
Bait Blast search results from 20
positive colonies (frequency of
more than 1 is indicated in
parentheses)
Coding region
characteristic
KLF4A
(1–170 aa)
JunD(2), IGKC, Small membrane
protein 1, macroglobulin a2,
SFTPA2, human upstream
binding transcription factor
In-frame
c-Jun(2), prothymosin, FKBP 1A,
ZFP36, MGAT1, galectin 1,
CALM3,DC class II
histocompatibility antigen a-chain
Not in-frame
KLF4B
(170–388 aa)
Tip60(3), FIM protein, BDR-1,
Ubc protein 38197157, PCDH16
In-frame
c-Jun (4), LDLR, SVAP1,DUSP4,
APBA3
Not in-frame
Note: in-frame indicates that amino acid coding results of DNA sequence
of positive clones are within the same open reading frame of GAL4
activation domain in the cloning vector. Not in-frame is the opposite.
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scriptional activation for  4- to 5-folds (Figure 3B). When
the N-terminal KLF4 was truncated from 76 to 117 aa,
transactivation activity decreased from 43- to 3-folds that
is consistent with published data showing a transactiva-
tion domain was located between 91 and 117 aa (3).
Interestingly, while Tip60 remained its ability to activate
KLF4-mediated transactivation (about 5-folds increase)
when N-terminal KLF4 was truncated to 76 aa, it had
minimal activation (about 1.4-fold) when N-terminal
KLF4 was further truncated to 117 aa, suggesting that
the region between 76 and 117 aa in KLF4 is required for
Tip60 to activated KLF4-mediated transcriptional activa-
tion. Expression of Tip60at a protein level by western
blotting analysis did not change in this reporter assay
(data not shown).
Tip60 andHDAC7 inhibit the HDCpromoter activity
Previously, Tip60 was reported to function as a
co-repressor for STAT3 with another protein HDAC7
(19). Tip60 and HDAC7 may therefore function similarly
for KLF4 in regulation of HDC promoter. To test this
possibility, diﬀerent amounts of either Tip60 or HDAC7
expressing constructs were cotransfected with either a
minimal 107bp HDC promoter reporter construct or a full
length 1.8kb HDC promoter reporter construct. Relative
promoter activities induced by transfection of plasmids
expressing Tip60 and HDAC7 were then measured 48h
after transfection. As shown in Figure 4A and B, both
Tip60 and HDAC7 dose-dependently inhibited HDC
promoter activity by this transient transfection assay,
where HDAC7 showed higher potency than did Tip60.
To conﬁrm the down-regulation of HDC promoter by
Tip60 and HDAC7, stable cell lines that speciﬁcally
express shRNA against Tip60 and HDAC7 were gener-
ated (Figure 4D). Consistent with the in vitro transfection
data, endogenous HDC mRNA levels in both Tip60
shRNA and HDAC7 shRNA expressing cell lines were
elevated (Figure 4C). In parallel, endogenous HDC
mRNA levels were downregulated upon exogenous
expression of Tip60 and HDAC7 (Figure 4E). These
data indicate that HDC gene expression is repressed by
Tip60 and HDAC7.
Tip60, KLF4and HDAC7 form acomplexand cooperatively
repressthe HDCpromoter activity
Previously, Tip60 has been reported to form a repressive
complex with HDAC7 and function as a corepressor
of STAT3. We postulated that Tip60 and HDAC7 may
function similarly as corepressors of KLF4 in regulation
of HDC gene expression. To test this possibility, physical
interactions between KLF4, Tip60 and HDAC7 were
examined in an immunoprecipitation assay. As shown
in Figure 5, HDAC7 were pulled down by both KLF4
(Figure 5A, top panel) and Tip60 (Figure 5B, top panel).
Together with coimmunoprecipitation between KLF4 and
Tip60 (Figure 1), the results suggest that these three
proteins form a complex. To test the functional
Figure 1. KLF4 interacted with Tip60 by coimmunoprecipitation assay. (A) Endogenous KLF4 interacted with endogenous Tip60. Total proteins
were immunoprecipitated with control IgG and anti-KLF4 and anti-Tip60 antibodies. The immunoprecipitates were then probed with anti-Tip60 and
anti-KLF4 antibodies. Total proteins were loaded as a control (B). KLF4 interacted with Tip60 in vitro. N-terminally HA-tagged KLF4 expression
plasmid (pHA-KLF4) and C-terminally FLAG-tagged Tip60 plasmid (pFLAG-Tip60) with the respective vectors were cotransfected in combination
into AGS cells. Total protein extracts were prepared 48h after transfection. Anti-HA antibody or Anti-FLAG antibody conjugated agarose beads
were added to protein extracts. After washing, immunoprecipitated proteins were separated on SDS-PAGE gel and then probed with diﬀerent
antibodies to detect interaction between KLF4 and Tip60.
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Figure 2. KLF4 disrupts Tip60-mediated transcriptional activation. (A) A reporter system (pGL5-GAL4-Luciferase) was shown where Tip60 was
recruited to the proximal promoter region by its Gal4 fusion domain to modulate transcription. (B) KLF4 disrupted Tip60-mediated transcriptional
activation. Plasmids expressing KLF4 (KLF4/HisB) and GAL4-fused wild-type and mutant Tip60 (pM-Tip60 and pM-Tip60M) with the respective
vectors were cotransfected in combination into AGS cells. Cells were lysed 48h after transfection followed by luciferase assay as described in
Materials and Methods section. Means SD for three independent experiments were shown. Statistical diﬀerence (P<0.05) of the relative promoter
activities of the transfection experiments was indicated by a star ( ). The bottom panel showed the protein levels by western blotting analysis in the
same transfection setting using anti-KLF4, anti-Tip60 and anti-a-tubulin antibodies. (C) KLF4 did not inﬂuence the function of VP16. As described
in panel B, similar transfection experiments were performed using KLF4 and VP16 expressing constructs to detect the eﬀect of KLF4 on VP16-
mediated transcriptional activation. The bottom panel showed the protein levels of KLF4 (Myc epitope-tagged) and a-tubulin. (D) Diﬀerent KLF4
truncation mutants were shown with the starting position of amino acids marked with numbers. (E) Expression of diﬀerent KLF4 truncation
mutants was shown. Total proteins were extracted 48h after transfection followed by western blotting analysis using anti-Myc antibody.
(F) Identiﬁcation of a functional domain in KLF4. A pM-Tip60 construct was cotransfected with diﬀerent KLF4 mutant constructs as shown in
panel D and the reporter into AGS cells. The relative reporter activities with diﬀerent KLF4 constructs were measured as described above.
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KLF4, Tip60 and HDAC7 expression constructs with
their respective vectors were cotransfected with the 1.8kb
and the 107-bp human HDC promoter reporter construct
into AGS cells to examine their eﬀect on the reporter
activity. As seen in Figure 5C and D, while the single or
double combination of Tip60, KLF4, and KLF4 showed
inhibitory activities in regulating the human HDC
reporter, the combination of these three proteins further
inhibited the promoter in the same transient cotransfec-
tion assays, suggesting that Tip60, KLF4 and HDAC7
cooperatively repress the activity of HDC promoter. In
addition, it appears that the major KLF4 response
element in HDC promoter (Sp1 binding GC box) is
important for Tip60 to inhibit the promoter activity, since
the mutation of this site abrogated the inhibitory eﬀect of
Tip60 alone and the combination eﬀect of KLF4 and
Tip60 (Figure 5E, bottom). As a control, Tip60 alone did
not have any inhibitory eﬀect on another KLF4 respon-
sive reporter (KLF4/pT81). Instead, it slightly relieved the
inhibitory eﬀect of KLF4 (Figure 5F). These data suggest
that KLF4 and Tip60 cooperatively repress transcription
of a subset of genes.
KLF4, Tip60 and HDAC7bind toHDC promoter by
chromatin immunoprecipitation (CHIP) assays
To investigate the in vivo regulation of HDC by KLF4,
Tip60 and HDAC7, in vivo binding of these proteins with
the promoter were examined by CHIP. Control rabbit IgG
and antibodies of KLF4, Tip60, HDAC7 and acetyl-H4
raised in rabbits were used to precipitate DNA–protein
complexes after formaldehyde ﬁxation and protein
extraction from AGSE cells. DNA samples were extracted
from the precipitates and were used as templates in PCR
with primer pairs to amplify a fragment of the proximal
HDC promoter region (promoter), a fragment in the ﬁrst
intron (Intron 1), and in the second intron (Intron 2) of
the HDC gene. As expected, a fragment in the HDC
promoter was ampliﬁed when anti-KLF4, Tip60 and
HDAC7 antibodies but not when control IgG was used,
suggesting that all three proteins bind the HDC promoter
in vivo (Figure 6A). Two hours of gastrin treatment, which
upregulates HDC gene expression (Figure 6B and C),
signiﬁcantly decreased the association of three proteins
with the promoter. Consistent with the activation of
transcription at the HDC promoter, histone acetylation
levels were increased after gastrin treatment as demon-
strated by increased binding of acetylated H4 with the
promoter. In contrast, binding of KLF4, Tip60, HDAC7
and acetyl-H4 to the intron 1 and 2 was not detected by
the same assay, suggesting that all these three proteins
bind speciﬁcally to the HDC promoter and the binding
is regulated by the status of active transcription. Gastrin-
induced dissociation of KLF4, Tip60 and HDAC7 with
the promoter appears not to occur at the RNA level, since
no decreased levels of mRNA of KLF4, Tip60 or HDAC7
were seen by quantitative real-time PCR, instead mRNA
levels of KLF4 and HDAC7 were upregulated by gastrin
treatment (Figure 6C).
DISCUSSION
In this study, we identiﬁed in yeast two-hybrid screening
Tip60 as a KLF4-interacting protein. Additional
cotransfection assays and coimmunoprecipitation analysis
suggested that Tip60 and HDAC7 form a complex with
KLF4 to regulate HDC promoter activity. The in vivo
association of a repressive complex on the HDC promoter
comprising KLF4, Tip60 and HDAC7 was further
supported by chromatin immunoprecipitation. Finally,
gastrin treatment, which activates HDC gene expression,
disrupted the association between KLF4, Tip60 and
HDAC7 with HDC promoter. Thus, our data provide
strongevidence thatTip60andHDAC7actas corepressors
of KLF4 in regulation of HDC gene expression.
The physical interaction between Tip60 and KLF4 is
not surprising given their share roles in DNA damage and
apoptosis and the fact that both proteins could be targeted
to proteasome-mediated degradation. The KLF4 protein
is an unstable protein with a half life of  120min. Its
levels in quiescent cells are high, but decrease rapidly after
cells are treated with serum. Serum-induced protein
degradation is partially mediated by the proteasome,
since the application of a proteasome inhibitor partially
inhibits the degradation (37). Biologically, KLF4 mod-
ulates p53-dependent G1/S cell cycle arrest in response to
DNA damage upon g–irradiation (10). Inhibition of p53
gene expression by KLF4 (14) further strengthens the
functional relationship between KLF4 and p53, although
the mechanism is not entirely clear. Similarly, Tip60 is
targeted by Mdm2 to a proteasome-mediated degradation
pathway and also accumulates after UV irradiation (38).
A  An artificial reporter system
B  Tip60 activates the function of KLF4
Figure 3. Tip60 activates KLF4-mediated transcriptional activation.
(A) As described in Figure 2A, a similar artiﬁcial promoter system was
used where KLF4 was recruited to the proximal promoter region.
(B) Tip60 and vector were cotransfected with diﬀerent pM/KLF4
constructs to test the function of Tip60 in KLF4-mediated transcrip-
tional regulation. The relative promoter activities were normalized with
the control KLF4 plasmid (pM) and with control Tip60 plasmid
(pCMV2).
Nucleic Acids Research, 2007, Vol. 35, No. 18 6143Furthermore, it has been established that Tip60 plays
a dual role in the p53 pathway. Under normal conditions,
Tip60 contributes maintenance of basal levels of p53 by
interfering with its degradation; after DNA damage,
Tip60 functions as p53 co-activator (39). Our results
showing a physical interaction between Tip60 and KLF4
provide additional possibility for how DNA damage
pathway could be controlled by diﬀerent proteins
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Figure 4. Tip60 and HDAC7 inhibited HDC promoter activity. (A) Tip60 dose-dependently inhibited both the full length (1.8kb, left panel) and
minimal (107bp, right panel) HDC promoter. HDC promoter reporter constructs were cotransfected with increasing amount of Tip60 expressing
construct into AGS cells. Forty-eight hours after transfection, cells were lysed, luciferase activities were measured and relative promoter activities
were calculated as described in Materials and Methods section. (B) HDAC7 dose-dependently inhibited HDC promoter activity. The experiments
were performed similarly as described in panel A. In both A and B, the total amount of plasmids in each transfection was 1mg. The space besides
Tip60 or HDAC7 construct was ﬁlled with the empty vector. For all these experiments, means SD for three independent experiments were shown.
(C) Endogenous HDC mRNA levels were elevated by knocking down Tip60 and HDAC7 gene expression. Total RNA was extracted from a control
cell line stably expressing a control shRNA, Tip60 shRNA and HDAC7 shRNA stably expressing cell lines. Reverse transcription was performed to
generate cDNA. RT-PCR was then followed to amplify a fragment of HDC cDNA and a fragment of GAPDH cDNA. PCR products were
separated on agarose gel and visualized under UV light. (D) Expression of Tip60 and HDAC7 in respective cell lines was shown that stably expressed
Tip60 or HDAC7 shRNA. RT-PCR was performed as described in panel C to amplify a fragment of Tip60 and HDAC7 cDNA. (E) Endogenous
HDC mRNA levels were downregulated by overexpression of exogenous Tip60 and HDAC7. Total RNA was extracted from AGS cells that
transfected with vector (pCMV2), Tip60 (pCMV2/Tip60) and HDAC7 (pCMV2/HDAC7). RT-PCR was performed as described above. One
representative of each shRNA cell line (control shRNA, Tip60 shRNA and HDAC7 shRNA), and one representative of Tip60 and HDAC7
overexpression experiments was shown from three independent experiments.
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Figure 5. KLF4, Tip60 and HDAC7 formed a complex and cooperatively inhibited HDC promoter activity. (A) HDAC7 was pulled down by KLF4.
Coimmunoprecipitation was performed using anti HA-tag antibody after transient transfection of pHA-KLF4 and pFLAG-HDAC7 constructs into
AGS cells as described in Methods and Materials section. Anti Flag-tag antibody was used to detect HDAC7 expression in the following western
blotting analysis. (B) HDAC7 was pulled down by Tip60. Similar to A, except anti-Tip60 antibody was used for immunoprecipitation. (C) KLF4,
Tip60 and HDAC7 cooperatively repressed 1.8kb HDC promoter activity. KLF4, Tip60, HDAC7 expressing plasmids with their respective vectors
were cotransfected into AGS cells in combination of three constructs with the full length 1.8kb HDC promoter reporter. Forty-eight hours after
transfection, cells were lysed, luciferase activities were measured and relative promoter activities were calculated as described in Materials and
Methods section. HDAC1 construct was also used as a control for HDAC7. (D) KLF4, Tip60 and HDAC7 cooperatively repressed 107bp HDC
promoter activity. Similar to panel C except the minimal 107bp human HDC promoter reporter was used instead of the full length 1.8kb HDC
reporter. (E) Tip60 lost its inhibitory eﬀect when a major KLF4 responsive element (Sp1 binding GC box) was mutated in the HDC promoter.
Cotransfection experiments were formed similarly as described above with wild-type 107bp human HDC promoter reporter (top) and mutant
reporter (bottom) with mutations in the upstream GC box. (F) Tip60 did not have any eﬀect on a KLF4 responsive artiﬁcial promoter.
Cotransfection experiments were formed similarly with an artiﬁcial reporter KLF4/pT81 with a KLF4 binding site and various combinations of
KLF4 and Tip60 overexpression constructs. A mutant reporter (KLF4M/pT81) with mutations in the KLF4 binding site was also used in the
experiment. Means SD for three independent experiments were shown for reporter assays (panels C–F), and major statistical diﬀerence (P<0.05)
of the relative promoter activities of the transfection experiments was indicated by a star (
 ).
Nucleic Acids Research, 2007, Vol. 35, No. 18 6145and how these proteins synchronize to protect the cells. It
is possible that under normal condition, KLF4 and Tip60
form a complex to regulate p53 stability. This hypothesis
is supported by the physical interaction between KLF4
and Tip60 (Figure 1) and between KLF4 and p53 (1), and
p53 degradation mediated by Mdm2 and Tip60 (38,39).
Tip60 possesses the intrinsic histone acetyltransferase
(HAT) activity, and recruitment of Tip60 to the proximal
promoter results in the transcriptional activation of an
artiﬁcial promoter (Figure 2B). This is consistent with the
notion that increased acetylation of histone tails is
associated with a transcriptional active state. However,
along with our ﬁndings, several reports have shown that
Tip60 can also repress transcription. Because of the
intrinsic HAT activity, it is diﬃcult to understand why
Tip60 inhibits transcription. There are several possibilities.
First, even though Tip60 can acetylate histone tails with
lower eﬃciency (34), the true substrates of Tip60 may be
some other cellular proteins that in turn regulate
transcription. For example, Tip60 has been shown to
acetylate both ATM (ataxia telangiectasia), a protein
kinase that regulates the cell’s response to DNA damage
(40), and androgen receptor (41). Second, Tip60 may
recruit transcriptional corepressors to repress transcrip-
tion. For example, Tip60 interacts with HDAC7, a protein
with histone deacetylases activity that is associated with
transcriptional repression, and functions as a corepressor
of STAT3 (19). The physical interaction between KLF4
and HDAC7 is consistent with this hypothesis. More
importantly, the interacting domain in Tip60 was located
in the region that is also required for its HAT activity (19).
These data suggest that HAT domain in Tip60 is not used
to acetylate any substrates; instead, it is responsible
for the recruitment of repressor such as HDAC7 to inhibit
transcription. Our data showed that HAT domain of
Tip60 is required for its transcriptional activation in an
artiﬁcial reporter system (Figure 2B). KLF4 completely
abrogated Tip60-mediated transcriptional activation to
a level that is similar to that mediated by HAT mutant
Tip60. This observation raises an intriguing possibility
that KLF4 inhibits the HAT activity of Tip60 by protein–
protein interaction with this HAT (MYST) domain.
Diﬀerent functions of KLF4 in two artiﬁcial systems
also appear confusing. In Figure 2B, KLF4 inhibits Tip60-
mediated transcriptional activation and in Figure 3B,
Tip60 activates KLF4-mediated transactivation. While an
artiﬁcial promoter and tagged protein constructs were
used in both systems that may complicate our interpreta-
tion, it is likely that they reﬂect diﬀerent roles of KLF4
in transcription: as a transcriptional activator and as
a transcriptional repressor, according to the cellular
context. For example, KLF4 has been show to inhibit
the transcription of p53 in human embryonic kidney cells
(Phoenix cells) (14). However, a more recent report
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Figure 5. Continued.
6146 Nucleic Acids Research, 2007, Vol. 35, No. 18indicated that KLF4 activates p53 transcription in
vascular smooth muscle cells (42). The fact that the
N-terminal domain of KLF4 between aa 76 and 117 is
required for Tip60 to activate KLF4-mediated transcrip-
tional activation is also interesting (Figures 2 and 3), since
the interaction domain in KLF4 with Tip60 is the middle
region between aa 117 and 388 from our initial yeast
two-hybrid screening. It is possible that Tip60 physically
interacts with KLF4at the middle region, and activates
KLF4-mediated transcriptional activation through the
N-terminal domain between aa 76 and 117. Further
mapping of interaction domains in Tip60 and KLF4 is
needed to understand how KLF4 and Tip60 function
coordinately to regulation transcription.
We have previously shown that HDC promoter was
inhibited by KLF4 mainly through the upstream Sp1
binding GC box. Our current ﬁnding provides an
additional mechanism of how KLF4 inhibits HDC
promoter activity through the upstream GC box. In
general, transcription factors recruit cofactors, either
coactivators or corepressors, to the proximal promoter
region. These cofactors then modify the structure of local
chromatin by changing the status of acetylation, phos-
phorylation and methylation of histone tails, which
resulting in the change of accessibility of transcriptional
machinery to the promoter and thus the change of
eﬃciency of transcription. In our system, KLF4 presum-
ably recruits Tip60 and HDAC7 as corepressor to the
upstream GC box, since mutation of the site disrupted the
inhibitory eﬀect of the complex (Figure 5E bottom panel).
Because of the deacetylase activity of HDAC7, which can
remove acetyl group from histone tails and is associated
with transcriptional inactive state, recruitment of Tip60/
HDAC7 complex will repress HDC transcription. Why
gastrin decreases binding of the KLF4-Tip60-HDAC7
complex to the HDC promoter (Figure 6A) despite the
fact that gastrin increases KLF4 and HDAC7 mRNA
levels (6C)? It is likely that gastrin activates Sp1 as
reported previously (43). As a result, the accumulation of
Sp1 on the HDC promoter would likely lead to decreased
binding of KLF4-Tip60-HDAC7 complexes on the HDC
promoter, since there is a competition between Sp1 and
KLF4 for binding, as we have reported earlier (36).
It should be noted that Tip60 does not repress expression
of all the genes that was inhibited by KLF4, suggesting
that KLF4, Tip60 and HDAC7 cooperatively repress
transcription of a subset of genes. The fact that inhibition
of HDC promoter activity by YY1 also occurs at the same
upstream GC box further suggests the importance of this
site in the basal and regulated HDC gene expression
(35,44). As previously described, YY1/SREBP-1a complex
may displace/compete with the binding of Sp1 with the
GC box, resulting in the repression of HDC promoter
activity. From our current study, it appears that the
KLF4/Tip60/HDAC7 repressive complex function simi-
larly to the YY1/SREBP-1a complex in regulation of
HDC promoter activity. However, the relationship
between these two complexes remains to be determined
(Figure 7).
Given that KLF4 and Tip60 are both involved in many
similar biological processes, including DNA damage and
apoptosis, the interaction between these two proteins will
likely provide more insights in deﬁning the mechanism
in these processes. Further studies may focus on the
change of interaction between KLF4 and Tip60 in some
physiological pathways such as DNA damage response
pathway. This will help in the development of KLF4
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Figure 6. KLF4, Tip60 and HDAC7 bind to HDC promoter by
chromatin immunoprecipitation assay. (A) Overnight starved AGSE
cells were treated with 10
 8M gastrin for 2h. Cells were then ﬁxed with
formaldehyde followed by protein extraction as described in Materials
and Methods section. Antibodies against KLF4, Tip60, HDAC7,
acetyl-H4 plus control IgG were used to precipitate DNA–protein
complexes. Puriﬁed DNA samples from precipitated DNA–protein
complexes were used as template for PCR to amplify a fragment of
HDC promoter, intron 1 and intron 2. (B) Gastrin treatment increased
107HDC promoter activity. Vector (pGL2), 107HDC reporter and
107HDCM reporter were transfected into AGSE cells. Before harvest-
ing, cells were treated with 10
 8M gastrin from 2h. Then, luciferase
assays were performed as described. (C) mRNA levels of KLF4, HDC,
Tip60 and HDAC7 after 10
 8M gastrin treatment were shown. Total
RNA was extracted after gastrin treatment at diﬀerent time points.
Reverse transcription and follow-up quantitative RT-PCR was
performed. Relative mRNA level was calculated as described in
Materials and Methods section. Means SD for three independent
experiments were shown, and statistical diﬀerence (P<0.05) of the
relative mRNA levels was indicated by a star (
 ).
Nucleic Acids Research, 2007, Vol. 35, No. 18 6147and/or Tip60 as a target for the treatment of various
diseases, including cancers, since DNA damage response
has been recently proposed as an early event during
tumorigenesis (35,45).
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